Bio-Quant is one of the industry's most experienced contract research organizations for contract drug discovery and development services in San Diego. Bio-Quant’s contract services business has been profitable since 2003 as revenues have grown 250% over the past three years. Bio-Quant conducts non GLP drug discovery research services specializing in oncology, inflammation, immunology, and diabetes. In addition, Bio-Quant’s functional high throughput screening capabilities provide customers with a rapid and unique way to discover lead compounds directed to inhibit direct cell function. Previous and current clients include Genzyme Corporation, Amgen, Momenta, Synta Pharmaceuticals, and Kinetic Concepts.